View All HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology
March 6, 2024 Southlake, TX, March 06, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused
Today Show highlights that AI-ECG is set to change medicine and save lives.
Excerpt from the Today Show. Watch the video using the following link: heartsciences.com/wp-content/uploads/2024/02/The-cutting-edge-way-doctors-are-using-AI-to-save-lives_1.mp4
How AI is Reshaping Diagnostic Tools
How AI is Reshaping Diagnostic Tools In healthcare, innovation saves lives. From the ECG discovery in 1895 to today’s AI breakthroughs, now AI is changing medicine. March 1, 2024
HeartSciences Appoints New Scientific Advisory Board Member
February 1, 2024 Southlake, TX, Feb. 01, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused
Supercharging the ECG: AI set to Revolutionise the Diagnostic Cardiology Market
Signify Research has just released a deep-dive qualitative analysis of developments around the use of AI to analyse and interpret electrocardiograms (ECGs), one of the world’s most ubiquitous diagnostic tests
HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting
January 18, 2024 Southlake, TX, Jan. 18, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused